Embracing Harm Reduction, FDA Gives E-Cigarette Industry a Regulatory Reprieve

Share

Embracing Harm Reduction, FDA Gives E-Cigarette Industry a Regulatory Reprieve

Kenneth Warner, a retired University of MI public health professor who is a leading authority on smoking and health, said he was pleasantly surprised to learn of the FDA announcement.

A critical component of the strategy, according to the FDA, is showing more awareness that nicotine reaches consumers through items that categorize a continuum of risk and is most harmful when delivered through smoke particles in combustible cigarettes.

"The FDA intends to start an open discourse about bringing down nicotine levels in ignitable cigarettes to non-addictive levels through achievable item models", the organization said in the declaration.

While the FDA's exertion is probably going to be vigorously restricted by cigarette creators, for example, Altria Group Inc. also, British American Tobacco Plc, the move by the office is gone for one of the U.S's. A new "comprehensive plan for tobacco and nicotine regulation" was launched that the FDA said will serve "as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death".

Tar and other substances inhaled through smoking make cigarettes deadly, but the nicotine in tobacco is what makes them addictive.

As for newer nicotine-delivery systems such as vaping and electronic cigarettes, the FDA says that makers of those and other newly regulated products will be given more time to submit them for review.

Neil Wilson of ETX Capital said it was "hard to overstate" what falling numbers of addicts and less frequent smoking could mean for corporate revenues.

In a statement, the regulator said it was aiming to create... In contrast, an e-cigarette can contain anywhere between zero milligrams and 42 milligrams of nicotine.

The agency is also seeking public comment on the role that flavors (including menthol) in tobacco products play in attracting new users, as well as additional input and scientific data on the patterns of use and public health impacts from premium cigars.

Altria Group, which sells Marlboro and other cigarettes in the US, said it would be "fully engaged" in FDA's rule-making process.

Share

Advertisement

© 2015 Leader Call. All Rights reserved.